Introduction {#s1}
============

Histamine \[2-(4-imidazolyl)-ethylamine\] is involved in a broad variety of (patho)-physiological processes, such as the regulation of gastric acid production, neurotransmission, and allergic and other inflammatory responses. To selectively exert these diverse functions, histamine binds to specific receptors of which four subtypes demonstrating selective expression patterns have been identified. These histamine receptors all belong to the class of G protein-coupled receptors and are referred to as H~1~-receptor (H~1~R), H~2~R, H~3~R and H~4~R ([@B1]). While the effects of histamine on gastric acid production and neurotransmission are mediated by H~2~R and H~3~R, respectively, the regulation of inflammatory responses by histamine involves H~1~R and H~4~R ([@B2], [@B3]).

Eosinophils functionally express the H~4~R ([@B4]--[@B8]). In primary human eosinophils, the *in vitro* ligand-mediated activation of H~4~R induces intracellular calcium ion mobilization and cell migration, but not reactive oxygen species production and degranulation. Moreover, calcium mobilization and migration are induced more effectively by e.g., eotaxin and fMLP, which also induce reactive oxygen species production and degranulation. Thus, in an *in vitro* setting, H~4~R mediates a rather partial activation of eosinophils ([@B8]). Whether this holds true also *in vivo* has not been addressed so far.

Elevated numbers of eosinophils and high histamine concentrations are found in inflamed colon tissues of patients suffering from inflammatory bowel diseases (IBD), which are idiopathic, chronic-recurring diseases of the gastrointestinal system with the two major clinical manifestations ulcerative colitis (UC) and Crohn\'s disease (CD) ([@B9]--[@B11]), as well as in cola of mice subjected to chemically induced colitis models ([@B12], [@B13]). While antagonists at the H~1~R are without clinical relevance in the treatment of IBD or in animal models, blockade of histamine production or H~4~R function is beneficial in specific colitis models, such as dextran sodium sulfate (DSS)-induced colitis in mice ([@B14]--[@B18]). Thus, DSS-induced colitis in mice provides a good and reliable model to study the effect of H~4~R on eosinophil function *in vivo*.

IL-5 also contributes to this process. Although recruitment of eosinophils to inflamed tissue is largely initiated by eotaxin, IL-5 contributes to this process, too ([@B19], [@B20]), and IL-5-deficient mice show a significant reduction in the overall numbers of eosinophils and in the prevalence of colon-infiltrating eosinophils during DSS-induced colitis ([@B13]).

Hence, in this study we adoptively transferred eosinophils from H~4~R-deficient (H~4~R^−/−^) and H~4~R-competent, i.e. wild-type (H~4~R^+/+^) mice into IL-5-deficient BALB/cJ mice and thereafter subjected these reconstituted mice to DSS-induced colitis. We demonstrate that IL-5 deficiency in BALB/cJ mice is protective against DSS-induced colitis and that adoptive transfer of eosinophils into these mice transiently reverts the acute colitis phenotype, eosinophils from H~4~R^+/+^ mice being more efficient than those from H~4~R^−/−^ mice. Moreover, the H~4~R on eosinophils promotes shifting the balance of the beginning local immune response toward the Th2 type ([@B13]).

Materials and methods {#s2}
=====================

Materials
---------

All chemicals and reagents used had been purchased from Sigma-Aldrich Chemie GmbH (Munich, Germany), if not stated otherwise.

Animals
-------

Animal housing and experimental procedures were approved by the animal welfare committee of the Hannover Medical School, complied with the German animal welfare legislation and were finally approved by the Lower Saxony State Office for Consumer Protection and Food Safety (LAVES, AZ 33.12-42502-04-12/1021). All mice were housed according to directive 2010/63/EU under specific pathogen-free conditions at the central animal facility of the Hannover Medical School and fed with standard diet (Altromin 1320, Altromin Spezialfutter GmbH & Co. KG, Lage, Germany). C57BL/6-Il5tm1Kopf/J mice ([@B21]) were purchased from Charles River Deutschland (Sulzbach, Germany) and backcrossed for at least ten generations onto BALB/cJRj mice purchased from Janvier Labs (Le Genest-Saint-Isle, France). Since then, the IL-5-deficient mice were routinely maintained as homozygous breeding. H~4~R^−/−^ mice (strain: C.129HrH${}_{4}^{\text{tm}1\text{Lex}}$) were generated by Lexicon Genetics (Woodlands, TX, USA) ([@B22]) and backcrossed for at least 10 generations onto the BALB/cJRj strain. Both H~4~R^+/+^ and H~4~R^−/−^ mice were bred from heterozygous matings of these founder animals. 8--10 weeks old male mice were used for the experiments. Littermates were chosen as control mice.

Generation of bone-marrow derived eosinophilic granulocytes (BM-Eos)
--------------------------------------------------------------------

BM-Eos were generated as previously described ([@B23]). Briefly, bone marrow was flushed from femorae and tibiae of donor mice (either H~4~R^+/+^ or H~4~R^−/−^ mice) with RPMI-1640 + 10% (v/v) Fetal Calf Serum (FCS), 2 mM EDTA. Erythrocytes were lysed by adding ice-cold 0.2% (w/v) NaCl in water to the pelleted cells. After 20 s, lysis was stopped by adding an equal volume of 1.6% (w/v) NaCl. Bone marrow cells were then cultured at 37°C, 5% (v/v) CO~2~ at 1 × 10^6^ cells/ mL in base medium \[RPMI-1640 + 20% (v/v) FCS, 25 mM HEPES, 100 IU/ml penicillin, 10 μg/ml streptomycin, 2 mM glutamine, 1 × NEAA (non-essential amino acids), 1 mM sodium pyruvate, 50 μM ß-Mercaptoethanol (β-MeSH)\] + 100 ng/ml SCF, 100 ng/ml Flt3-L (both PeproTech GmbH, Hamburg, Germany) for 4 days. From day 4 on, the cells were cultured in base medium + 40 ng/ml IL-5 (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany). Cells were used between 10 and 12 days after initiation of the culture and were routinely \>90% eosinophils as detected by flow cytometric evaluation of Siglec-F expression (Anti-Siglec-F, mouse, clone: ES22-10D8; Miltenyi Biotec GmbH, Bergisch Gladbach, Germany).

Induction of colitis by DSS, adoptive transfer of BM-Eos and animal dissection
------------------------------------------------------------------------------

Acute colitis was induced at day 0 by adding 3% (w/v) DSS (36,000--50,000 Da; MP Biomedicals, Santa Ana, CA, USA) to their drinking water. DSS was fed to the mice of the colitis groups from day 0 to day 7. Water-fed mice served as control. On day 2, BM-Eos were suspended in RPMI-1640 at 1 × 10^7^ cells/ ml and 200 μL of this cell suspension per mouse (= 2 × 10^6^ cells) were injected intravenously into the tail veins of IL-5-deficient mice (Figure [1](#F1){ref-type="fig"}). WT or IL-5-deficient mice without i.v. injection of cells served as DSS-fed controls. On day 7, mice were sacrificed by exsanguination after sedation with CO~2~, the sera were collected and the cola and ceca were removed. The lengths of cola and ceca were measured and the collected tissues were washed with PBS to remove remaining feces. One third of each colon was fixed in 4% (v/v) formaldehyde in PBS, embedded in paraffin, and further processed for hematoxylin/eosin (H&E) staining. Another third of each colon was stored in RNAlater for qPCR analyses, the remaining third of each colon was snap frozen in 2 mL Matrix D FastPrep® tubes (MP Biomedicals, Santa Ana, CA, USA). Mesenteric lymph nodes were removed and a lymphocyte enriched single cell suspension was generated by passing the tissue through a sterile 100 μm mesh with 5 mL RMPI-1640 medium.

![Schematic representation of the experimental settings. Not shown are the control settings water- and DSS-fed WT mice and water-fed IL-5-deficient mice without reconstitution of eosinophils.](fimmu-09-02119-g0001){#F1}

Generation of colon homogenates and supernatants of mesenteric lymph nodes
--------------------------------------------------------------------------

Mesenteric lymph node cells were seeded at 1 × 10^6^ cells/ml 200 μl/well in RPMI-1640 + 10% (v/v) FCS, 50 μM ß-MeSH on a 96 well-plate, and incubated at 37°C, 5% (v/ v) CO~2~ for 24 h in the absence or presence of CD3-antibody (EXBIO Praha, Vestec u Prahy, Czech Republic). After the incubation period, cell-free supernatants were generated by centrifugation at 300 g for 10 min at 4°C. Colon tissues were homogenized either for cytokine measurements in ice cold PBS + 1x protease inhibitor cocktail (Cell Signaling Technology, Frankfurt, Germany) or for RNA extraction in lysis buffer RA1 (Macherey Nagel, Düren, Germany) supplemented with 150 mM ß-MeSH using the FastPrep® 24 homogenizer and 2 mL Matrix D FastPrep® tubes (both from MP Biomedicals, Santa Ana, CA, USA) according to the manufacturer\'s instructions for intestinal tissue.

Cytokine measurements
---------------------

Concentrations of Ccl2, Cxcl1, Cxcl2, interleukin (IL)-1β, IL-5, IL-6, IL-10, IL-12p70, IL-17A, IL-23p19, interferon (IFN)-γ, and TNF were measured in colon homogenates, sera, and cell-free supernatants of αCD3-stimulated lymph node cells with a customized multiplex magnetic Luminex Kit (R&D Systems, Minneapolis, MN, USA). Myeloperoxidase concentrations were evaluated using a commercially available DuoSet ELISA Kit (R&D Systems, Minneapolis, MN, USA). Cytokine measurements in colon tissue were normalized to the total protein content of the homogenates.

Quantitative real-time PCR
--------------------------

Total RNA was extracted from colon tissue stored in RNAlater with NucleoSpin® RNA II kit (Macherey Nagel, Düren, Germany) according to the manufacturer\'s instruction. cDNA was prepared from 1 μg of total RNA by reverse transcription for 30 min at 50°C with Maxima Reverse Transcriptase (Thermo Fisher Scientific, Waltham, MA, USA). Sequences specific for the transcription factors Tbet1 (Assay ID: Mm00450960_m1) and Gata3 (Mm00484683_m1) were quantified in relation to Gapdh (Mm99999915_g1) as reference gene using TaqMan™ assays (Thermo Fisher Scientific, Waltham, MA, USA).

Evaluation of disease activity
------------------------------

The disease severity of colitic mice was assessed daily by calculating a disease activity index (DAI) ranging from 0 to 12. The DAI is based on total body weight loss (0: no weight loss, 1: 1--5%, 2: 5--10%, 3: 10--15%, 4: \>15%), stool consistency (0: normal, 2: soft, 4: diarrhea) and rectal bleeding (0: no bleeding, 2: little bleeding, 4: massive bleeding).

Histological analysis
---------------------

H/E-stained tissue slices of colon segments were analyzed in a blinded fashion by two independent researchers. A modified histological severity score ([@B24]) was calculated by evaluating overall severity of inflammation (0: normal, 1: mild, 2: moderate, 3: severe, 4: severe with affection of serosa), hyperplasia of crypts (0: no, 2: yes), degree of ulceration (0: no ulcers, 1: 1--2 ulcers involving up to 20 crypts, 2: 1--4 ulcers involving 20 to 40 crypts, 3: any ulceration exceeding the aforementioned criteria), submucosal edema (0: no, 1: yes), bleeding (0: no, 1: yes) and the total area of affected tissue (0: 0%, 1: ≤ 30%, 2: ≤ 70%, 3: \>70%). The maximum score thus sums up to 14. Infiltration of eosinophilic granulocytes into inflamed cola was quantified by counting the eosinophils in four high power field micrographs of submucosal edema in relation to the total number of submucosal immune cells.

Statistical analysis
--------------------

Data are represented as arithmetic mean of replicates ± 95% CI for each parameter. Group sizes were *n* = 5 (WT, +DSS), 5 (IL-5-deficient, not reconstituted, +DSS), 7 (IL-5-deficient, reconstituted, -DSS), 10 (IL-5-deficient, reconstituted, +DSS). Outliers as identified using ROUT with an aggressiveness Q of 0.1%, were removed before subsequent analyses. Statistical analyses were performed with GraphPad Prism version 6.07 for Windows (GraphPad Software, La Jolla, CA, USA) using two-way ANOVA with *post-hoc* Tukey test for evaluating significance during the repeated measurements of DAI and body weight and one-way ANOVA with *post-hoc* Holm-Sidak test for evaluating significance in all other measurements. Differences between group means were considered significant if *p* \< 0.05.

Results {#s3}
=======

Colitis was induced by DSS application in BALB/cJ WT mice and in BALB/cJ IL-5-deficient mice either or not reconstituted with isogenic bone marrow-derived eosinophils. The transferred eosinophils had an either H~4~R^+/+^ or an H~4~R^−/−^ genotype. For a period of 7 days after induction of colitis, the mice\'s body weights (Figure [2A](#F2){ref-type="fig"}) ([@B16]) and disease activity indices (DAI; Figure [2B](#F2){ref-type="fig"}) were recorded daily and calculated, respectively. In control mice, which were fed pure water without DSS, body weight increased by roughly 5% during the observation period of 7 days, while stool consistency remained normal and perianal bleedings were not observed. Thus, for control mice the DAI score was 0 for the whole observation period (Figure [2B](#F2){ref-type="fig"}). Compared to WT mice, lack of IL-5 expression in BALB/cJ mice significantly ameliorated DSS-induced body weight loss (Figure [2A](#F2){ref-type="fig"}) and delayed the onset of enhanced DAI (Figure [2B](#F2){ref-type="fig"}). Reconstitution of IL-5-deficient mice with eosinophils led to an aggravation of DSS-induced clinical signs of colitis (Figures [2A,B](#F2){ref-type="fig"}), the H~4~R^+/+^ eosinophils\' transfer resulting in an earlier onset and a faster enhancement of the DAI than the H~4~R^−/−^ eosinophils\' transfer. Thus, the expression of H~4~R on eosinophils affects the kinetics of clinical signs occurring in acute DSS-induced colitis in BALB/cJ mice.

![Clinical and macroscopic analyses. WT mice and IL-5-deficient mice, either left not reconstituted (IL-5 KO) or reconstituted with eosinophils obtained from IL-5-competent isogeneic wild-type (H~4~R^+/+^) or H~4~R-deficient (H~4~R^−/−^) mice, were fed with water containing DSS for 7 days. During this period, the clinical parameters body weight (**A**; due to severe symptoms DSS-fed WT mice had to be taken off the experiment at day 6), stool consistency, and perianal bleeding (not reported) were recorded and evaluated according to a scoring system. The three individual parameters are summarized to obtain the disease activity index (DAI) **(B)** \[means ± 95% CI; *n* = 5 (WT +DSS), 5 (IL-5 KO, +DSS), 7 (reconstituted, -DSS), 10 (reconstituted, +DSS); 2-way ANOVA with Tukey\'s post-test (vs. IL-5 KO): ^+^*p* \< 0.05, ^++^*p* \< 0.01, ^+++^*p* \< 0.001, ^++++^*p* \< 0.0001\].](fimmu-09-02119-g0002){#F2}

Morphological and histological alterations of caeca and cola are parameters indicative for colitis. Application of DSS in the drinking water significantly reduced the lengths of cola (Figure [3A](#F3){ref-type="fig"}) and caeca (Figure [3B](#F3){ref-type="fig"}) in eosinophil-reconstituted IL-5-deficient mice. Differences between DSS-treated mice either or not reconstituted with eosinophils were detected neither in caeca nor in cola. Hence, also the genotype of the transferred eosinophils did not affect the lengths\' reduction (Figures [3A,B](#F3){ref-type="fig"}). Histological examination of the colon tissues revealed similar degrees of DSS-induced destruction in not reconstituted and in reconstituted IL-5-deficient mice, which was again not affected by the eosinophils\' genotype (Figures [3C,D](#F3){ref-type="fig"}). All samples of DSS-treated mice show severe edema formation, crypt deformation, and inflammatory infiltrations (Figure [3C](#F3){ref-type="fig"}). Within these submucosal infiltrations, the percentage of eosinophils was similar in tissues obtained from not reconstituted and from reconstituted IL-5-deficient mice (Figure [3E](#F3){ref-type="fig"}). As observed in preliminary experiments, about 15% of the transferred eosinophils (4.5 × 10^6^; i.v. injection) could be recovered in lung, spleen, and liver 1 day after injection, the by far most of them residing in the liver. However, at the end of the 7 days observation period no transferred eosinophils could be identified any more among the eosinophils in the intestinal infiltrations.

![Histological analyses. IL-5-deficient mice were either left not reconstituted (none) or were reconstituted with eosinophils obtained from IL-5-competent isogeneic wild-type (H~4~R^+/+^) or H~4~R-deficient (H~4~R^−/−^) mice and then fed with water either or not containing DSS for 7 days. At day seven, the mice were dissected and the lengths of cola **(A)** and ceca **(B)** were recorded. The cola were histologically prepared, stained with H&E (**C**; exemplary photographs) and quantitatively analyzed using a defined scoring system in a blinded manner **(D)**. Eosinophils within the infiltrations were identified and quantitated using 3--4 high power field areas per colon **(E)** (single values and means ± 95% CI; 1-way ANOVA with Holm-Sidak\'s post-test: \*\**p* \< 0.01, \*\*\**p* \< 0.001, \*\*\*\**p* \< 0.0001).](fimmu-09-02119-g0003){#F3}

The DSS-induced inflammatory reaction in the colon was evaluated by analyzing the local mediator expression (Figure [4A](#F4){ref-type="fig"}). DSS feeding led to an enhanced production of CXCL1, CXCL2, IL-6, TNF, and MPO, and a reduced production of IL-10 in IL-5-deficient mice, which was not affected by reconstitution of the mice with eosinophils, independently of the genotype of the transferred cells (Figure [4A](#F4){ref-type="fig"}). No significant differences between DSS-fed and not DSS-fed mice were found in IL-1β, IL-12, IL-17, IL-23, and IFNγ production (Table [1A](#T1){ref-type="table"}). In cells obtained from the gut-draining lymph nodes of IL-5-deficient mice, αDC3-re-stimulation resulted in only slight tendencies toward an enhanced production of the mediators IL-6, IL-10, IL-17, and IFNγ due to the previous *in vivo* DSS application (Figure [4B](#F4){ref-type="fig"}). For the expression of CXCL1, CXCL2, TNF, IL-1β, IL-12, and IL-23 such trends were not observed (Figure [4B](#F4){ref-type="fig"}, Table [1B](#T1){ref-type="table"}). Thus, regarding these end-point parameters, no function can be attributed to the H~4~R on eosinophils.

![Cytokine production in cola and re-stimulated lymph node cells. IL-5-deficient mice were either left not manipulated (none) or were reconstituted with eosinophils obtained from IL-5-competent isogeneic wild-type (H~4~R^+/+^) or H~4~R-deficient (H~4~R^−/−^) mice and then fed with water either or not containing DSS for 7 days. At day seven, the mice were dissected and cola and mesenteric lymph nodes were obtained. Cola were homogenized and cleared, and lymph nodes were processes to single cells, which were stimulated *in vitro* with CD3 antibodies. Cytokine concentrations were measured in colon homogenates **(A)** and conditioned lymph node cell supernatants **(B)** by multiplex assays (single values and means ± 95% CI; outliers, identified using ROUT with an aggressiveness Q of 0.1%, were removed; 1-way ANOVA with Holm-Sidak\'s post-test: \**p* \< 0.05, \*\**p* \< 0.01, \*\*\**p* \< 0.001).](fimmu-09-02119-g0004){#F4}

###### 

Cytokine concentrations in colon tissue (pg/mg tissue; mean ± SD).

  **Reconst. eos**   **DSS feeding**   **IL-1β**   **IL-12p70**   **IL-17A**   **IL-23p19**   **IFNγ**
  ------------------ ----------------- ----------- -------------- ------------ -------------- ----------
  None               \+                81 ± 16     9 ± 4          \< LLOQ      112 ± 26       \< LLOQ
  H~4~R^+/+^         --                91 ± 32     8 ± 5          \< LLOQ      142 ± 70       \< LLOQ
  H~4~R^−/−^         --                79 ± 15     7 ± 2          \< LLOQ      130 ± 24       \< LLOQ
  H~4~R^+/+^         \+                86 ± 25     9 ± 3          \< LLOQ      104 ± 21       \< LLOQ
  H~4~R^−/−^         \+                80 ± 24     9 ± 4          \< LLOQ      106 ± 33       \< LLOQ

###### 

Cytokine concentrations in supernatants of re-stimulated lymph node cells (pg/ml; mean ± SD).

  **Reconst. eos**   **DSS feeding**   **TNF**    **IL-1β**   **IL-12p70**   **IL-23p19**
  ------------------ ----------------- ---------- ----------- -------------- --------------
  None               \+                191 ± 30   299 ± 10    \< LLOQ        262 ± 53
  H~4~R^+/+^         --                129 ± 51   126 ± 157   \< LLOQ        180 ± 79
  H~4~R^−/−^         --                102 ± 88   98 ± 152    \< LLOQ        175 ± 86
  H~4~R^+/+^         \+                144 ± 62   236 ± 124   \< LLOQ        273 ± 104
  H~4~R^−/−^         \+                141 ± 64   177 ± 152   \< LLOQ        282 ± 120

Since histamine via the H~4~R is able to modulate T-cell polarization, the expressions of Th1- and Th2-specific transcription factors were measured in colonic tissues to analyze the local immune response. While the expression of Th1-specific Tbet was not affected by DSS-feeding nor by the transfer of eosinophils (Figure [5A](#F5){ref-type="fig"}), Th2-specific GATA3 expression was significantly enhanced due to the transfer of H~4~R^+/+^ eosinophils to IL-5-deficient mice in combination with DSS feeding, while transfer of H~4~R^−/−^ eosinophils and DSS feeding did not result in such an enhancement (Figure [5B](#F5){ref-type="fig"}). Thus, in contrast to H~4~R^−/−^ eosinophils, H~4~R^+/+^ eosinophils promote the infiltration of affected colon tissue by Th2 cells in BALB/cJ mice.

![Th1/Th2-type transcription factor expression in cola. IL-5-deficient mice were either left not manipulated (none) or were reconstituted with eosinophils obtained from IL-5-competent isogeneic wild-type (H~4~R^+/+^) or H~4~R-deficient (H~4~R^−/−^) mice and then fed with water either or not containing DSS for 7 days. At day seven, the mice were dissected and cola were obtained. RNA was extracted from cola and the relative quantity of T-bet **(A)** and GATA3 **(B)** was analyzed by RT-qPCR (single values and means ± 95% CI; 1-way ANOVA with Holm-Sidak\'s post-test: \**p* \< 0.05, \*\*\**p* \< 0.001).](fimmu-09-02119-g0005){#F5}

Discussion {#s4}
==========

Eosinophils functionally express H~4~R, which is involved in regulation of the cells\' migration and activation ([@B4], [@B6], [@B8]). However, in *in vitro* systems, histamine, as compared to other stimuli, is only a partial activator of eosinophils ([@B8]). In the present study, we aimed at analyzing the role of H~4~R on eosinophils *in vivo*, employing DSS-induced colitis in mice, a model for human UC. The pathophysiological manifestations of UC and DSS-induced colitis are caused by an underlying inflammatory immune response, which essentially depends on the presence of eosinophils and their products ([@B25]--[@B27]).

IL-5 is a pathogenic factor in DSS-induced acute colitis in BALB/cJ mice
------------------------------------------------------------------------

Differentiation of eosinophils from progenitor cells in the bone marrow is driven by IL-5 in concert with IL-3 and GM-CSF. Moreover, IL-5 stimulates the newly generated eosinophils\' mobilization and promotes their eotaxin-mediated recruitment to the gastrointestinal tract ([@B19], [@B20]). Although in mice lacking IL-5 expression the infection-induced enhancement of eosinophil numbers is abolished ([@B21]), IL-5 deficiency is reported to be without effect on the pathogenesis of acute DSS-induced colitis ([@B13], [@B26]). These latter studies, however, were performed using mice on a C57Bl/6 background, which differ in their susceptibility to induction of acute colitis by DSS as compared to BALB/cJ mice ([@B28], [@B29]). Moreover, in contrast to C57Bl/6 mice, BALB/cJ mice are prone to preferentially mount a Th2-type immune response, and Th2 cells are the main T cell subset found in inflammatory infiltrations in both human UC and DSS-induced colitis in mice ([@B30]--[@B32]). Consequently, in the present study we observed that lack of IL-5 expression in BALB/cJ mice delays the appearance of typical clinical symptoms. Hence, the disease-aggravating effect of IL-5 on acute DSS-induced colitis indeed depends on the genetic background of the mouse model employed. Such marked strain-dependent differences between BALB/c and C57Bl/6 mice have already been observed in other experimental models ([@B33]). Lastly, one has to keep in mind that none of the different animal model fully resembles human IBD but only some specific features. Hence, DSS-feeding induces a pathology representing the acute inflammation occurring in UC, while TNBS administration more closely models CD. Moreover, the genotype of a given individual, mouse or man, can affect the degree of polarization of an occurring immune response. Thus, caution has to be paid when aiming at transferring results obtained using a congenic strain of mice to the genetically inhomogeneous human population.

The pathogenic effect of eosinophils in acute DSS-induced colitis is promoted by the H~4~R
------------------------------------------------------------------------------------------

The delayed early kinetic of DSS-induced colitis symptoms in IL-5-deficient mice is reversed by reconstituting the mice with H~4~R^+/+^ eosinophils. Thus, this model provides a reliable *in vivo* system to analyze the contribution of eosinophils.

The capacity of the transferred eosinophils to revert the clinical phenotype of DSS-treated IL-5-deficient mice is affected to only a minor extent by the H~4~R genotype of the donor mice. Moreover, the effect of the eosinophils\' transfer on the signs of colitis is only transient, being virtually absent at day 7 after colitis induction. This transient kinetic and the rather small difference between the effects of reconstituting eosinophils obtained from H~4~R^+/+^ or H~4~R^−/−^ mice in this model indicates that also *in vivo* histamine via the H~4~R only partially activates eosinophils, which is in accordance with the corresponding *in vitro* observations ([@B8]).

H~4~R on eosinophils shifts the local immune response toward the Th2 type
-------------------------------------------------------------------------

Only the transfer of eosinophils obtained from H~4~R^+/+^ mice, but not that from H~4~R^−/−^ mice results in a significantly enhanced GATA3 expression in the inflamed colon. Similar observations were also made in biopsies obtained from patients suffering from active UC, in which GATA3 expression correlated with disease activity, and in mice with colitis induced by oxazolone treatment ([@B34]). GATA3 is of relevance for the differentiation of breast and urogenital epithelial tissues and of Th2 cells, but it is virtually absent in respiratory and gastrointestinal epithelia ([@B35]). Moreover, overexpression of GATA3 in T cells accelerates colitis induced in mice by DSS feeding ([@B36]). Thus, the enhanced expression of GATA3 observed in the present colitis study indicates a local immune response biased toward the Th2-type which is supported by the H~4~R genotype of the transferred eosinophils. Such an effect of the H~4~R on polarization of an immune response has so far been ascribed only to dendritic cells, in which the H~4~R is involved in the regulation of cytokine and chemokine production ([@B37]--[@B41]). The precise mechanism, however, by which mechanism the H~4~R on eosinophils affects the polarization of the immune response in DSS-induced colitis in BALB/cJ mice still has to be elucidated.

In conclusion (Figure [6](#F6){ref-type="fig"}), this study indicates that, as observed already *in vitro*, also *in vivo*, in the mouse model of DSS-induced colitis, histamine via the H~4~R only partially activates eosinophils with respect to the acute inflammatory reaction. Here, probably other innate immune cells, such as mast cells provide the major H~4~R contribution ([@B42]). On the initiating adaptive immune response, however, H~4~R on eosinophils seem to provide a regulatory function.

![Schematic representation of the H~4~R function on eosinophils in experimental colitis (HA, histamine; MC, mast cell; Eo, eosinophil; Th1/Th2, T helper 1/2 cell).](fimmu-09-02119-g0006){#F6}
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